CVS HEALTH CORP (CVS) Institutional Ownership Changes & 13F Activity
CVS HEALTH CORP (CVS) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Dodge & Cox Stock Fund, Hancock Classic Value, Ariel Appreciation Fund, Renaissance Technologies LLC, and Sequoia Financial Advisors.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q4 2024 | Sequoia Financial Advisors | Sell | -6,551 | 41,157 | $1,847,534 |
| Q4 2024 | Matrix Private Capital Group | Sell | -4,518 | 7,222 | $324,211 |
| Q4 2024 | Hillman Value Fund | Sell | -1,891 | 119,636 | $5,370,460 |
| Q4 2024 | Matrix Advisors Value Fund | Sell | -986 | 6,175 | $277,196 |
| Q3 2024 | Third Point | Buy | 1,575,000 | 1,575,000 | $99,036,000 |
| Q3 2024 | Dodge & Cox Stock Fund | Buy | 1,347,347 | 63,030,690 | $3,963,369,787 |
| Q3 2024 | Renaissance Technologies LLC | Buy | 338,800 | 967,153 | $60,814,581 |
| Q3 2024 | Hancock Classic Value | Buy | 198,920 | 13,135,308 | $825,948,167 |
| Q3 2024 | Turtle Creek Asset Management | Sell | -56,490 | 2,097,667 | $131,901,301 |
| Q3 2024 | Ariel Appreciation Fund | Sell | -52,277 | 616,807 | $38,784,824 |
| Q3 2024 | Sound Shore Management | Sell | -25,019 | 1,140,812 | $71,734,258 |
| Q3 2024 | Sequoia Financial Advisors | Buy | 15,741 | 47,708 | $2,999,860 |
| Q3 2024 | Matrix Advisors Value Fund | Sell | -11,400 | 7,161 | $450,284 |
| Q3 2024 | Olstein Capital Management | Buy | 10,000 | 165,000 | $10,375 |
| Q3 2024 | Hillman Value Fund | Sell | -2,802 | 121,527 | $7,641,618 |
| Q3 2024 | Matrix Private Capital Group | Sell | -1,373 | 11,740 | $738,232 |
| Q3 2024 | Cullen Value Fund | Sell | -1,060 | 30,174 | $1,897,318 |
| Q2 2024 | Dodge & Cox Stock Fund | Buy | 20,670,800 | 61,683,343 | $3,643,018,238 |
| Q2 2024 | Hancock Classic Value | Buy | 7,382,931 | 12,936,388 | $764,023,075 |
| Q2 2024 | Turtle Creek Asset Management | Buy | 436,891 | 2,154,157 | $127,224,512 |
| Q2 2024 | Matrix Advisors Value Fund | Sell | -265,183 | 18,561 | $1,096,000 |
| Q2 2024 | Sound Shore Management | Sell | -154,662 | 1,165,831 | $68,853,979 |
| Q2 2024 | Ariel Appreciation Fund | Buy | 62,475 | 669,084 | $39,516,101 |
| Q2 2024 | Olstein Capital Management | Buy | 26,000 | 155,000 | $9,154 |
| Q2 2024 | Hillman Value Fund | Buy | 10,291 | 124,329 | $7,342,860 |
| Q2 2024 | Sequoia Financial Advisors | Sell | -8,420 | 31,967 | $1,887,999 |
| Q2 2024 | Cullen Value Fund | Sell | -5,767 | 31,234 | $1,844,700 |
| Q2 2024 | Matrix Private Capital Group | Sell | -108 | 13,113 | $774,454 |
| Q1 2024 | Dodge & Cox Stock Fund | Buy | 10,599,153 | 41,012,543 | $3,271,160,430 |
| Q1 2024 | Hancock Classic Value | Buy | 4,729,207 | 5,553,457 | $442,943,731 |
Frequently asked questions about CVS activity
Which institutional owners are buying CVS?
Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CVS activity?
"Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CVS increasing?
Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CVS insights
- CVS Overview
- CVS Institutions
- CVS Institutional Ownership
- CVS Top Shareholders
- CVS Institutional Buying
- CVS Institutional Selling
- CVS Ownership Changes
- CVS Insiders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Owners in Q1 2026
- Most Sold Healthcare Stocks By Institutional Owners in Q1 2026
- Top Institutional Investor Stock Rankings